DURHAM, N.C., Jan. 27 /PRNewswire/ -- bioMerieux, a world leader in the field of in vitro diagnostics, entered into an exclusive referral agreement on January 15, 2009 with ICNet Systems, Inc., a leading international solution provider of healthcare-associated infection (HAI) case management and surveillance software.
"Microbiology and serology data drive the activity around infection control surveillance," said Herb Steward, executive vice president and general manager, bioMerieux North America. "ICNet Systems, Inc. offers our customers an important tool in the fight against HAIs, a strategic focus at bioMerieux."
Through electronic interfacing with third party database management systems, laboratory information systems (LIS), patient administration/hospital information systems and surgical systems, ICNet automates the collection of data required by the infection control teams (ICT), providing real time alerts, reports and analytical tools that save considerable IC time and help target action more effectively.
ICNet is a web-enabled application that helps hospitals reduce medication costs through the more expeditious and appropriate use of real-time microbiology diagnostic data management, surveillance and reporting. The use of the software can assist in decreasing the risk of spreading preventable infections through timelier root cause analysis once a problem has been identified.
"ICNet is renowned for quality software, service and support, so it was essential to find a partner that would maintain these standards in USA," said Katie Houghton, CEO and co-founder of ICNet Ltd. "bioMerieux met our criteria for a respected and established company that specializes in microbiology, has an accomplished sales force and highly skilled technical and implementation teams."
About ICNet Systems, Inc.
ICNet Ltd is a global clinical informatics company dedicated to improving efficiency within infection control teams, through providing innovative and best of breed case management and surveillance software. Founded in 2000 and privately owned, ICNet Ltd is based in Gloucestershire England with affiliated companies and distributors in most continents of the world, including ICNet Systems Inc based in Nashville, TN.
ICNet Ltd designs, develops and supports a multi-lingual and web-based software solution that is used globally serving about 1,000 Hospitals. International growth has been rapid in recent years boosted by aggressive policies adopted by Governments to encourage public reporting of Healthcare Associated Infections (HAI) and the determination of the healthcare community as a whole to reduce HAI, thus saving very significant amounts of hospital expense and improving patient safety and Hospital profitability. Other information can be found at http://www.icnetplc.com.
Advancing Diagnostics to Improve Public Health
A world leader in the field of in vitro diagnostics for over 45 years, bioMerieux is present in 150 countries through 39 subsidiaries and a large network of distributors. In 2008, revenues reached euro 1.111 billion with 84% of sales outside of France.
bioMerieux provides diagnostic solutions (reagents, instruments, software) that determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMerieux is listed on the NYSE Euronext Paris market (Code: BIM - Code ISIN: FR0010096479). Other information can be found at http://www.biomerieux.com.
Copyright©2009 PR Newswire.
All rights reserved